Chondroitin sulfate glycosaminoglycan chain (CS-GAG)

Calcium-binding sites on chondroitin sulfate glycosaminoglycan chains are specific anionic regions within the chondroitin sulfate (CS) polysaccharide where divalent calcium ions interact with carboxylate and sulfate groups. Chondroitin sulfate is a major structural component of the extracellular matrix (ECM) in cartilage, bone, and connective tissues, consisting of repeating disaccharide units of N-acetylgalactosamine and glucuronic acid (PubChem CID 24766). These calcium-binding sites are critical for maintaining the structural integrity, hydration, and osmotic pressure of the ECM, as well as regulating the local concentration of calcium ions for processes like bone mineralization (PMID: 15501345). In clinical practice, exogenous chondroitin sulfate is utilized as a symptomatic slow-acting drug for osteoarthritis (SYSADOA) to promote matrix synthesis and inhibit degradative enzymes such as matrix metalloproteinases (DrugBank DB09301). Furthermore, the interaction between calcium and CS is a key factor in the development of calcified tissues and is implicated in pathological conditions like vascular calcification and atherosclerosis (PMID: 19054136). The binding affinity for calcium is influenced by the sulfation pattern of the CS chain, which varies across different tissues and developmental stages.

Other names

Chondroitin sulfateCSChondroitin 4-sulfateChondroitin 6-sulfateGalactosaminoglycanChondroitin sulfuric acid

Exogenous chondroitin sulfate serves as a substrate for the synthesis of the extracellular matrix and inhibits the activity of matrix metalloproteinases and inflammatory cytokines like IL-1beta. The calcium-binding sites on these chains are essential for the structural stabilization of the matrix and the regulation of calcium-dependent signaling and mineralization processes (DrugBank DB09301; PMID: 6771145).